New research published in Developmental Cell provides evidence that targeting the KCNB2 gene could enhance current cancer treatments, tackling medulloblastoma tumor growth. Tumor-propagating cells ...

SickKids researchers identified the KCNB2 gene as a key driver of medulloblastoma tumor growth. Blocking KCNB2 disrupts potassium channels, causing tumor-propagating cells to swell and lose integrity.